You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Hamilton Niagara Haldimand Brant Regional Cancer Program

The Hamilton Niagara Haldimand Brant Regional Cancer Program oversees the quality and delivery of cancer services for the areas of Brant, Burlington, Haldimand, Hamilton, Niagara and Norfolk.

Service Partners

Juravinski Cancer Centre

The Juravinski Cancer Centre (JCC) serves more than 1.4 million people from the Hamilton Niagara Haldimand Brant Local Health Integration Network and over 2 million Ontarians for selected services. The JCC sees more than 7,500 new patients each year. As a regional cancer centre, the JCC partners with other institutions and care providers to deliver high quality cancer care close to home. Its facilities include 10 linear accelerators and is 1 of 2 Ontario regional cancer centres to provide CyberKnife Radiosurgery.

The cancer centre serves approximately 40,000 people identifying as First Nation, Inuit, or Metis living in the region. This includes approximately 28,000 members of 1 of the 2 First Nations reserves: Six Nations of the Grand River Territory and Mississaugas of the New Credit First Nation. The region is also home to 2 Metis Nation of Ontario Councils (The Niagara Region Metis Council and the Hamilton-Wentworth Metis Council) as well as growing urban Indigenous populations.

In September 2014, the state-of-the-art CIBC Breast Assessment Centre opened to provide comprehensive, multidisciplinary expertise and care in the diagnosis of breast cancer, including a high-risk genetics program. The centre won the CCO Annual Quality Award in 2015 for its radiology/pathology rounds process and also received design awards, including the prestigious International Future Health Design Award.

Researchers at JCC and partner hospitals throughout the region, in collaboration with McMaster University, are international leaders in cancer research. They make significant contributions to the growing body of knowledge about cancer treatment and control around the world. The JCC includes a highly developed cancer clinical trials program. As an academic health sciences centre, the JCC is actively involved in educating and mentoring the next generation of physicians, health professionals and researchers.

A Patient Family Advisory Committee was implemented in 2013 to act as an advisory and information sharing body on matters critical to patients and families. The committee strives to enhance patient-centred care and improve the overall patient experience. A Patient and Family Resource Centre, conveniently located in the main lobby, provides information and a quiet place for reading.

Walker Family Cancer Centre

The Walker Family Cancer Centre opened in 2013 in St. Catharines. It is a major cancer care partner in the Local Health Integration Network and serves as the hub of coordinated cancer services for Niagara. The centre serves more than 2,500 new patients annually.

As a multidisciplinary facility, the centre provides cancer services in prevention, screening, supportive care, systemic and radiation treatment. The facility has 3 linear accelerators. It also has a well-established Cancer Council and Patient and Family Advisory Council.

Partner Hospitals


Cancer Care Ontario Regional Vice-President, Hamilton Niagara Haldimand Brant Regional Cancer Program

Dr. Ralph Meyer

Dr. Ralph Meyer received his medical degree from McMaster University in 1978. He completed residency training in internal medicine (1982) and hematology (1984) at McMaster University and joined the Department of Medicine in 1984. His academic interests included clinical trials and implications for health policy for hematologic malignancies, including international leadership roles in the study of the malignant lymphomas. He previously chaired the Hematology Site Committees of the National Cancer Institute of Canada (NCIC) Clinical Trials Group and Cancer Care Ontario’s Program in Evidence-Based Care.

In April 2006, Dr. Meyer joined the NCIC Clinical Trials Group and in 2007 became the group’s Director, and Edith and Carla Eisenhauer Chair in Clinical Cancer Research. He was also professor in the Departments of Oncology, Medicine, and Community Health and Epidemiology at Queen’s University.

In August 2013, Dr. Meyer returned to Hamilton as the Hamilton Niagara Haldimand Brant Regional Vice-President for CCO, Vice-President of Oncology and Palliative Care at Hamilton Health Sciences and professor in the Department of Oncology at McMaster University.